Back to School: How biopharma can reboot drug development. Access exclusive analysis here

CPC-111 small molecule facilitator of anaerobic glycolysis: Began Phase II trial in the U.K. to measure post-operative myocardial performance of heart bypass pa

Cypros Pharmaceutical Corp. (CYPR), Carlsbad, Calif.

Read the full 63 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE